FUJIFILM Holdings Corporation

4901.T · JPX

Company research

FUJIFILM Holdings Corporation (TSE: 4901) is a Japanese multinational conglomerate founded in 1934 and headquartered in Tokyo, Japan, originally established as a photographic film manufacturer before successfully transforming into a diversified global technology company. The company operates across four core business segments — Healthcare, Electronics, Business Innovation, and Imaging — with Healthcare now representing a significant revenue driver through medical devices, biomedical CDMO services, pharmaceuticals, and regenerative medicine. Under the leadership of President and CEO Teiichi Goto, FUJIFILM generated approximately ¥3.36 trillion in revenue in FY2026, employing over 73,500 staff across 258 consolidated subsidiaries worldwide. Listed on the Tokyo Stock Exchange with a market capitalization of approximately ¥4.3 trillion, the company stands as a notable case study in corporate transformation, leveraging its core chemical and materials technologies to diversify well beyond its photographic origins.

Research reports

Zacks Investment Research · January 11, 2026Zacks Equity Research Report for FUJIY (FUJIFILM Holdings Corp)

Zacks assigns FUJIFILM an Outperform recommendation and Zacks Rank 1-Strong Buy with a 6–12 month price target of 13.00 USD versus a spot price of 10.52 USD, citing strong momentum across Imaging Solutions, Healthcare, and Bio CDMO, record recent revenues and profits, and continued product innovation and capacity expansion. The report highlights raised fiscal 2025 revenue guidance, robust Instax and digital camera demand, and major Bio CDMO contracts as key growth drivers, while flagging tariff uncertainties, macro headwinds, a leveraged balance sheet, and intense competition as principal risks to execution.